Mandate

Vinge advises Gotlandsbolaget in connection with off-take agreement regarding biogas

February 17, 2025 Commercial Agreements M&A

Vinge has advised Rederiaktiebolaget Gotland (Gotlandsbolaget) in connection with the entry into of a strategic off-take agreement, which secures the long-term supply of biogas for the Gotland ferry service traffic.

Gotlandsbolaget aims to offer climate-neutral crossings between Gotland and the mainland by 2045. In order to do this, large volumes of fossil-free fuels are required. Vinge has advised Gotlandsbolaget in an investment in the construction of a biogas plant outside Eskilstuna for the production of high-quality biogas and the negotiation and execution of a 10-year off-take agreement regarding the purchase and delivery of the biogas produced. As a result of this transaction, Gotlandsbolaget has taken important steps towards achieving its goal of climate-neutral crossings between Gotland and the mainland. The plant is expected to be operational in 2026.

 

Vinge’s team consisted primarily of Malin Ohlin and Mario Saad.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026